SCHEDULE 13D

Company

BIOLARGO, INC.

Filed

October 18, 2000

Accession Number

0000897069-00-000506

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →